In all patients with<unk>  cardiomyopathy risk stratification is essential to attempt to ascertain which patients are at risk for sudden cardiac death. In those patients deemed to be at high risk, the benefits and infrequent complications of defibrillator therapy are discussed; devices have been implanted in as many as 15% of patients at HOCM centers.<unk>  symptoms of obstructive HOCM is directed towards decreasing the left ventricular outflow tract gradient and symptoms of dyspnea, chest pain and syncope.
Hypertrophic cardiomyopathy medical treatment
Hypertrophic cardiomyopathy medical therapy
Chronic mitral regurgitation treatment
Noncompaction cardiomyopathy medical therapy
Stress cardiomyopathy medical therapy
Aortic stenosis medical therapy
Hypertrophic cardiomyopathy interventions
Dilated cardiomyopathy medical therapy